|
|
Name: |
Cormorant Asset Management LLC |
City: |
BOSTON |
State: |
MA |
Zip: |
02110 |
|
|
|
Achive
data |
View
Filing Period: |
|
|
|
|
|
|
Download |
|
|
|
|
|
Free Registration Required For Full Results
|
|
|
Holdings
Found :
17 |
|
View All Holdings |
Currently
Viewing:
New Positions |
|
|
Page 1 of 1 |
Menu
|
Ticker |
Company Name |
Position Rank |
New/Closed Postion |
Last Close |
Value |
Shares Held |
% of Portfolio |
Value Change |
Change In Shares Held |
% of Company |
Industry |
|
CRBP |
Corbus Pharmaceuticals Hold... |
7 |
New |
$50.10 |
$79,461,000 |
2,025,000 |
3.5% |
79,461,000 |
2,025,000 |
1.616 |
N/A |
|
NAMS |
Newamsterdam Pharma Ord Shs |
17 |
New |
$0.00 |
$35,475,000 |
1,500,000 |
1.56% |
35,475,000 |
1,500,000 |
1.839 |
N/A |
|
CGON |
CG Oncology, Inc |
18 |
New |
$34.66 |
$35,120,000 |
800,000 |
1.55% |
35,120,000 |
800,000 |
1.212 |
N/A |
|
MRUS |
Merus Nv |
21 |
New |
$56.55 |
$32,196,000 |
715,000 |
1.42% |
32,196,000 |
715,000 |
1.239 |
N/A |
|
HLXB |
Helix Acquisition Corp. Ii |
24 |
New |
$10.24 |
$30,254,000 |
2,909,000 |
1.33% |
30,254,000 |
2,909,000 |
15.81 |
N/A |
|
TRML |
Tourmaline Bio |
26 |
New |
$0.00 |
$28,625,000 |
1,250,000 |
1.26% |
28,625,000 |
1,250,000 |
3.026 |
N/A |
|
JANX |
Janux Therapeutics, Inc. |
27 |
New |
$0.00 |
$28,238,000 |
750,000 |
1.24% |
28,238,000 |
750,000 |
1.88 |
N/A |
|
ARQT |
Arcutis Biotherapeutics, Inc. |
32 |
New |
$8.63 |
$21,059,000 |
2,125,000 |
0.93% |
21,059,000 |
2,125,000 |
1.996 |
N/A |
|
ATXS |
Astria Therapeutics, Inc |
35 |
New |
$9.15 |
$18,298,000 |
1,300,000 |
0.81% |
18,298,000 |
1,300,000 |
2.378 |
N/A |
|
ENGN |
Engene Holdings Inc. |
36 |
New |
$9.00 |
$16,950,000 |
1,000,000 |
0.75% |
16,950,000 |
1,000,000 |
4.31 |
N/A |
|
VTYX |
Ventyx Biosciences, Inc. |
38 |
New |
$2.88 |
$14,905,000 |
2,710,000 |
0.66% |
14,905,000 |
2,710,000 |
5.388 |
N/A |
|
NKTX |
Nkarta, Inc. |
39 |
New |
$0.00 |
$14,594,000 |
1,350,000 |
0.64% |
14,594,000 |
1,350,000 |
2.774 |
N/A |
|
SLN |
Silence Therapeutics Adr Re... |
40 |
New |
$0.00 |
$13,500,000 |
625,000 |
0.59% |
13,500,000 |
625,000 |
2.097 |
N/A |
|
MRSN |
Mersana Therapeutics, Inc. |
41 |
New |
$2.07 |
$11,648,000 |
2,600,000 |
0.51% |
11,648,000 |
2,600,000 |
2.156 |
N/A |
|
CMPX |
Compass Therapeutics Ord Shs |
42 |
New |
$0.00 |
$11,009,000 |
5,560,300 |
0.49% |
11,009,000 |
5,560,300 |
5.672 |
N/A |
|
KYTX |
Kyverna Therapeutics |
43 |
New |
$9.53 |
$10,930,000 |
440,000 |
0.48% |
10,930,000 |
440,000 |
1.023 |
N/A |
|
AVBP |
Arrivent Biopharma, Inc. |
46 |
New |
$18.70 |
$9,198,000 |
515,000 |
0.41% |
9,198,000 |
515,000 |
1.538 |
N/A |
|